Yoichiro Natori
Overview
Explore the profile of Yoichiro Natori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichimaru N, Natori Y, Alloway R, Wojciechowski D, Castillo Almeida N, Futamura K, et al.
Transplantation
. 2025 Mar;
PMID: 40072882
Background: Kidney transplantation (KT) has dramatically improved the quality of life of patients with end-stage kidney disease. However, the incidence of opportunistic infections has also increased because of immunosuppression. A...
2.
Natori Y, Martin E, Mattiazzi A, Arosemena L, Burke G, Munagala M, et al.
Immunol Lett
. 2025 Jan;
273:106968.
PMID: 39798807
Introduction: In Solid Organ Transplant (SOT) recipients, due to immunosuppression, the immunogenicity after COVID-19 vaccination is suboptimal and its durability is unknown. Methods: We conducted a post-hoc analysis of a...
3.
Unagami K, Yoshikawa M, Egawa H, Ohfuji S, Natori Y, Oki R, et al.
Vaccine
. 2024 Aug;
42(23):126221.
PMID: 39180977
Poor post-vaccination production of antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a concern among solid organ transplant (SOT) recipients. Furthermore, the timing and kinetics of antibody titers...
4.
Ljungman P, Chemaly R, Khawaya F, Alain S, Avery R, Badshah C, et al.
Clin Infect Dis
. 2024 Jul;
79(3):787-794.
PMID: 39041385
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of...
5.
Lin R, Anderson A, Natori Y, Raja M, Morris M, Jimenez A, et al.
Blood Adv
. 2024 Jun;
8(14):3813-3822.
PMID: 38838226
Cytomegalovirus (CMV) reactivation is a major complication among seropositive allogeneic hematopoietic cell transplantation recipients; however, data on CMV reactivation after chimeric antigen receptor (CAR) T-cell therapy are limited. We report...
6.
Kimura M, Rinaldi M, Kothari S, Giannella M, Anjan S, Natori Y, et al.
Am J Transplant
. 2024 May;
24(11):2092-2107.
PMID: 38801991
Invasive aspergillosis (IA) is a rare but fatal disease among liver transplant recipients (LiTRs). We performed a multicenter 1:2 case-control study comparing LiTRs diagnosed with proven/probable IA and controls with...
7.
Camargo J, Natori Y
Clin Infect Dis
. 2024 Apr;
79(6):1534-1535.
PMID: 38571315
No abstract available.
8.
Osman L, Lopez C, Natori Y, Anjan S, Bini Viotti J, Simkins J
Microorganisms
. 2024 Mar;
12(3).
PMID: 38543646
complex (MABC), a rapidly growing , is one of the most common causes of non-tuberculous mycobacteria (NTM) infections in the United States of America, and it has been associated with...
9.
Yamanaga S, Shimata K, Ohfuji S, Yoshikawa M, Natori Y, Hibi T, et al.
Am J Transplant
. 2024 Mar;
24(8):1495-1508.
PMID: 38514016
The excess mortality of coronavirus disease 2019 (COVID-19) solid organ transplant recipients (SOTRs) throughout the pandemic remains unclear. This prospective cohort study based on the Japanese nationwide registry included 1632...
10.
Yoshikawa M, Natori Y, Oki R, Unagami K, Ohfuji S, Imamura R, et al.
Scand J Immunol
. 2024 Mar;
98(4):e13308.
PMID: 38441221
The coronavirus disease-19 (COVID-19) vaccine efficacy and immunogenicity in the immunocompetent population are well established. However, in solid organ transplant (SOT) recipients, because of their use of immunosuppressive medication, the...